Gareth Bryson

Medical Protective — United States

Medicine · Health Sciences

14h-index995citations56works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(14), Cancer Cells and Metastasis(12), AI in cancer detection(8), Proteoglycans and glycosaminoglycans research(8), Radiomics and Machine Learning in Medical Imaging(7)

Publications56 total

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2025Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2025Open Access
Estimands for Clinical Effectiveness of Risk-Reducing Early Salpingectomy in Women With High Risk of Ovarian Cancer
JAMA Network Open·2025· 1 citedOpen Access
Endometrial Whole Slide Images Dataset
2025
54P A large-scale multi-site validation of a deep learning approach for determining ER, PR, and HER2 status from H&E-stained breast cancer slides
ESMO Open·2025Open Access
Cervical whole-slide images dataset for multiclass classification.
PubMed·2025Open Access
Endometrial whole-slide images dataset for detection of malignancy in endometrial biopsies.
PubMed·2025Open Access
Cervical Whole Slide Images Dataset
2024
Cervical Whole Slide Images Dataset
2024
Abstract PO3-07-05: Multi-site validation of a deep learning solution for ER/PR profiling of breast cancer from H&E-stained pathology slides
Cancer Research·2024· 1 cited
Automated reporting of cervical biopsies using artificial intelligence
PLOS Digital Health·2024· 4 citedOpen Access
583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study
2024
652 Chemokine CCL21 induces an immunotolerant tumour microenvironment leading to poorer survival in ovarian cancer
2024Open Access
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Nature Communications·2023· 3 citedOpen Access
Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023Open Access
Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023Open Access
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Darren Ennis(19), Iain A. McNeish(19), Rosalind Glasspool(18), Suzanne Dowson(16), Hasan Mirza(15), Gwo‐Yaw Ho(12), Elizabeth L. Kyran(12), Justin Bedő(12), Matthew J. Wakefield(12), Cassandra J. Vandenberg(12), Elizabeth Lieschke(12), Olga Kondrashova(12), Rosanna Upstill‐Goddard(12), Ulla‐Maja Bailey(12), Patricia Roxburgh(12), Andrew V. Biankin(12), Susanna L. Cooke(12), Gayanie Ratnayake(12), Orla McNally(12), Nadia Traficante(12)